Understanding the Radiobiological Mechanisms Induced by 177Lu-DOTATATE in Comparison to External Beam Radiation Therapy
Delbart, Wendy, Karabet, Jirair, Marin, Gwennaëlle, Penninckx, Sébastien, Derrien, Jonathan, Ghanem, Ghanem E., Flamen, Patrick, Wimana, Zéna
Published in International journal of molecular sciences (15.10.2022)
Published in International journal of molecular sciences (15.10.2022)
Get full text
Journal Article
Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [177Lu]Lu-DOTATATE in a panel of cancer cell lines
Delbart, Wendy, Ghanem, Ghanem E., Karfis, Ioannis, Flamen, Patrick, Wimana, Zéna
Published in Nuclear medicine and biology (01.05.2021)
Published in Nuclear medicine and biology (01.05.2021)
Get full text
Journal Article
Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
Mileva, Magdalena, Marin, Gwennaëlle, Levillain, Hugo, Artigas, Carlos, Van Bogaert, Camille, Marin, Clémentine, Danieli, Rachele, Deleporte, Amelie, Picchia, Simona, Stathopoulos, Konstantinos, Jungels, Christiane, Vanderlinden, Bruno, Paesmans, Marianne, Ameye, Lieveke, Critchi, Gabriela, Taraji-Schiltz, Loubna, Velghe, Chloe, Wimana, Zéna, Bali, Maria, Hendlisz, Alain, Flamen, Patrick, Karfis, Ioannis
Published in The Journal of nuclear medicine (1978) (01.02.2024)
Published in The Journal of nuclear medicine (1978) (01.02.2024)
Get full text
Journal Article
Everolimus-induced somatostatin receptor overexpression in a rectal neuroendocrine tumor patient may promote somatostatin receptor-guided radionuclide therapy (peptide receptor radiotherapy) as an additional treatment option
Mileva, Magdalena, Wimana, Zéna, Flamen, Patrick, Karfis, Ioannis
Published in World journal of nuclear medicine (01.07.2021)
Published in World journal of nuclear medicine (01.07.2021)
Get full text
Journal Article
Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)
Mileva, Magdalena, de Vries, Elisabeth G. E., Guiot, Thomas, Wimana, Zéna, Deleu, Anne-Leen, Schröder, Carolien P., Lefebvre, Yolene, Paesmans, Marianne, Stroobants, Sigrid, Huizing, Manon, Aftimos, Philippe, Tol, Jolien, Van der Graaf, Winette T. A., Oyen, Wim J. G., Vugts, Danielle J., Menke-van der Houven van Oordt, C. Willemien, Brouwers, Adrienne H., Piccart-Gebhart, Martine, Flamen, Patrick, Gebhart, Géraldine
Published in NPJ breast cancer (06.01.2024)
Published in NPJ breast cancer (06.01.2024)
Get full text
Journal Article
Integrating molecular imaging and transcriptomic profiling in advanced HER2-positive breast cancer receiving trastuzumab emtansine (T-DM1): an analysis of the ZEPHIR clinical trial
Rediti, Mattia, Fimereli, Danai, Mileva, Magdalena, Wimana, Zéna, Venet, David, Flamen, Patrick, Guiot, Thomas, de Vries, Elisabeth G E, Schröder, Carolina P, Menke-van der Houven van Oordt, C Willemien, Maetens, Marion, Majjaj, Samira, Larsimont, Denis, Rothé, Françoise, Sotiriou, Christos, Gebhart, Géraldine
Published in Clinical cancer research (29.10.2024)
Published in Clinical cancer research (29.10.2024)
Get full text
Journal Article
Prediction of 177 Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
Mileva, Magdalena, Marin, Gwennaëlle, Levillain, Hugo, Artigas, Carlos, Van Bogaert, Camille, Marin, Clémentine, Danieli, Rachele, Deleporte, Amelie, Picchia, Simona, Stathopoulos, Konstantinos, Jungels, Christiane, Vanderlinden, Bruno, Paesmans, Marianne, Ameye, Lieveke, Critchi, Gabriela, Taraji-Schiltz, Loubna, Velghe, Chloe, Wimana, Zéna, Bali, Maria, Hendlisz, Alain, Flamen, Patrick, Karfis, Ioannis
Published in Journal of Nuclear Medicine (21.12.2023)
Published in Journal of Nuclear Medicine (21.12.2023)
Get full text
Journal Article
Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [89Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model
Wimana, Zéna, Gebhart, G., Guiot, T., Vanderlinden, B., Morandini, R., Doumont, G., Sherer, F., Van Simaeys, G., Goldman, S., Ghanem, G., Flamen, P.
Published in Molecular imaging and biology (01.10.2015)
Published in Molecular imaging and biology (01.10.2015)
Get full text
Journal Article
Everolimus-induced somatostatin receptor overexpression in a rectal neuroendocrine tumor patient may promote somatostatin receptor-guided radionuclide therapy
Wimana, ZéNa, Karfis, Ioannis, Mileva, Magdalena, Flamen, Patrick
Published in World journal of nuclear medicine (01.07.2021)
Get full text
Published in World journal of nuclear medicine (01.07.2021)
Journal Article
Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177 Lu-DOTATATE
Delbart, Wendy, Marin, Gwennaëlle, Stamatopoulos, Basile, de Wind, Roland, Sirtaine, Nicolas, Demetter, Pieter, Vercruyssen, Marie, Woff, Erwin, Karfis, Ioannis, Ghanem, Ghanem E, Flamen, Patrick, Wimana, Zéna
Published in Cancers (17.04.2023)
Get full text
Published in Cancers (17.04.2023)
Journal Article
177 Lu-DOTATATE PRRT Safety and Organ-at-Risk Dosimetry in Patients With Gastroenteropancreatic Neuroendocrine Tumors : Data From the Prospective Phase 2 LUMEN Study
Mileva, Magdalena, Van Bogaert, Camille, Marin, Gwennaëlle, Danieli, Rachele, Artigas, Carlos, Levillain, Hugo, Ameye, Lieveke, Taraji-Schiltz, Loubna, Stathopoulos, Konstantinos, Wimana, Zéna, Hendlisz, Alain, Flamen, Patrick, Karfis, Ioannis
Published in Clinical nuclear medicine (01.09.2024)
Published in Clinical nuclear medicine (01.09.2024)
Get more information
Journal Article
Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE
Delbart, Wendy, Marin, Gwennaëlle, Stamatopoulos, Basile, de Wind, Roland, Sirtaine, Nicolas, Demetter, Pieter, Vercruyssen, Marie, Woff, Erwin, Karfis, Ioannis, Ghanem, Ghanem E., Flamen, Patrick, Wimana, Zéna
Published in Cancers (17.04.2023)
Published in Cancers (17.04.2023)
Get full text
Journal Article
Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with [sup.177]Lu-DOTATATE
Delbart, Wendy, Marin, Gwennaëlle, Stamatopoulos, Basile, de Wind, Roland, Sirtaine, Nicolas, Demetter, Pieter, Vercruyssen, Marie, Woff, Erwin, Karfis, Ioannis, Ghanem, Ghanem E, Flamen, Patrick, Wimana, Zéna
Published in Cancers (01.04.2023)
Published in Cancers (01.04.2023)
Get full text
Journal Article
Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with 177LuLu-DOTATATE in a panel of cancer cell lines
Delbart, Wendy, Ghanem, Ghanem E, Karfis, Ioannis, Flamen, Patrick, Wimana, Zéna
Published in Nuclear medicine and biology (01.05.2021)
Published in Nuclear medicine and biology (01.05.2021)
Get full text
Journal Article
Prediction of 177 Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
Mileva, Magdalena, Marin, Gwennaëlle, Levillain, Hugo, Artigas, Carlos, Van Bogaert, Camille, Marin, Clémentine, Danieli, Rachele, Deleporte, Amelie, Picchia, Simona, Stathopoulos, Konstantinos, Jungels, Christiane, Vanderlinden, Bruno, Paesmans, Marianne, Ameye, Lieveke, Critchi, Gabriela, Taraji-Schiltz, Loubna, Velghe, Chloe, Wimana, Zéna, Bali, Maria, Hendlisz, Alain, Flamen, Patrick, Karfis, Ioannis
Published in The Journal of nuclear medicine (1978) (01.02.2024)
Get full text
Published in The Journal of nuclear medicine (1978) (01.02.2024)
Journal Article
N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89Zr-Trastuzumab and 18F-FDG PET imaging
Wimana, Zéna, Gebhart, Geraldine, Guiot, Thomas, Vanderlinden, Bruno, Larsimont, Denis, Doumont, Gilles, Van Simaeys, Gaetan, Goldman, Serge, Flamen, Patrick, Ghanem, Ghanem
Published in Oncotarget (22.08.2017)
Published in Oncotarget (22.08.2017)
Get full text
Journal Article
Downregulation of the FTO m 6 A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors
Jeschke, Jana, Collignon, Evelyne, Al Wardi, Clémence, Krayem, Mohammad, Bizet, Martin, Jia, Yan, Garaud, Soizic, Wimana, Zéna, Calonne, Emilie, Hassabi, Bouchra, Morandini, Renato, Deplus, Rachel, Putmans, Pascale, Dube, Gaurav, Singh, Nitesh Kumar, Koch, Alexander, Shostak, Kateryna, Rizzotto, Lara, Ross, Robert L, Desmedt, Christine, Bareche, Yacine, Rothé, Françoise, Lehmann-Che, Jacqueline, Duterque-Coquillaud, Martine, Leroy, Xavier, Menschaert, Gerben, Teixeira, Luis, Guo, Mingzhou, Limbach, Patrick A, Close, Pierre, Chariot, Alain, Leucci, Eleonora, Ghanem, Ghanem, Yuan, Bi-Feng, Willard-Gallo, Karen, Sotiriou, Christos, Marine, Jean-Christophe, Fuks, François
Published in Nature cancer (01.06.2021)
Get more information
Published in Nature cancer (01.06.2021)
Journal Article
N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89 Zr-Trastuzumab and 18 F-FDG PET imaging
Wimana, Zéna, Gebhart, Geraldine, Guiot, Thomas, Vanderlinden, Bruno, Larsimont, Denis, Doumont, Gilles, Van Simaeys, Gaetan, Goldman, Serge, Flamen, Patrick, Ghanem, Ghanem
Published in Oncotarget (22.08.2017)
Get full text
Published in Oncotarget (22.08.2017)
Journal Article
Prostate-specific membrane antigen (PSMA) expression in patients with metastatic triple negative breast cancer: Initial results of the PRISMA study
Nader Marta, Guilherme, Wimana, Zena, Taraji, Loubna, Critchi, Gabriela, Aftimos, Philippe Georges, Piccart-Gebhart, Martine J., Flamen, Patrick, Gebhart, Geraldine
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle
Bartelink, Imke H., Jones, Ella F., Shahidi‐Latham, Sheerin K., Lee, Pei Rong Evelyn, Zheng, Yanan, Vicini, Paolo, ‘t Veer, Laura, Wolf, Denise, Iagaru, Andrei, Kroetz, Deanna L., Prideaux, Brendan, Cilliers, Cornelius, Thurber, Greg M., Wimana, Zena, Gebhart, Geraldine
Published in Clinical pharmacology and therapeutics (01.07.2019)
Published in Clinical pharmacology and therapeutics (01.07.2019)
Get full text
Journal Article